The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its blockbuster drug Wegovy.

U.S. conflict will be contained. Israel accused Iran of violating a ceasefire that U.S. President Donald Trump laid out. Novo Nordisk has ended its collaboration with telehealth company Hims & ...

Stock markets have rallied after U.S. President Donald Trump announced a ceasefire in the Israel-Iran conflict, although the ...

Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ...

Hims & Hers delivered record Q1 results and expanded into Europe with the Zava acquisition. Click here to see why HIMS stock is a Hold.

Novo Nordisk, the company behind blockbuster weight-loss drugs like Ozempic and Wegovy, had a deal with Hims & Hers that ...

The Danish maker of obesity drugs abruptly ended a Wegovy distribution deal with the telehealth firm, citing allegations ...

Rio Tinto, Hancock to Jointly Invest $1.6 Billion in Hope Downs 2 Project Rio Tinto said the development of the Hope Downs 2 project with Hancock Prospecting would involve two new pits that will churn ...

Hims & Hers Health’s stock booked record losses Monday after Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ...

The calming in the oil market came as several analysts said Iran would likely refrain from closing the waterway. Iran itself ...